From standard therapies to monoclonal antibodies and immune checkpoint inhibitors – an update for reconstructive surgeons on common oncological cases

Malignancies represent a persisting worldwide health burden. Tumor treatment is commonly based on surgical and/or non-surgical therapies. In the recent decade, novel non-surgical treatment strategies involving monoclonal antibodies (mAB) and immune checkpoint inhibitors (ICI) have been successfully...

Descripció completa

Dades bibliogràfiques

Autors principals:	Leonard Knoedler, Lioba Huelsboemer, Katharina Hollmann, Michael Alfertshofer, Konstantin Herfeld, Helia Hosseini, Sam Boroumand, Viola A. Stoegner, Ali-Farid Safi, Markus Perl, Samuel Knoedler, Bohdan Pomahac, Martin Kauke-Navarro
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-04-01
Col·lecció:	Frontiers in Immunology
Matèries:	breast cancer sarcoma head and neck cancer skin cancer malignant melanoma monoclonal antibody
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1276306/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!